Our data showing that Axl deficiency in bone marrow-derived cells does not affect the most important parameters of advanced atherosclerosis is quite surprising and cannot be explained by compensatory up-regulation of MerTK or Tyro3. This evidence concerns the gene AXL and atherosclerosis.